当前位置:首页 > 股票大全 > 双鹭药业 002038 财务分析

双鹭药业财务分析

整理编辑：168股票行情网：www.gphq168.com    数据来源：互联网 经供参考

双鹭药业(002038)利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入245,116,238.481,018,358,696.85776,629,583.53583,506,665.49
营业总成本136,620,657.72765,793,318.81552,257,886.29355,340,102.68
营业利润71,156,814.33477,869,983.57344,612,259.87350,358,045.79
利润总额71,158,314.34464,894,309.39344,637,149.36350,374,147.81
净利润69,675,806.49414,957,464.48316,227,670.71316,179,332.84
其他综合收益-12,807,829.6--
综合收益总额69,675,806.49427,765,294.08316,227,670.71316,179,332.84
双鹭药业(002038)资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计2,675,312,708.262,639,981,026.242,048,072,703.912,039,044,474.34
非流动资产合计3,636,647,291.513,637,780,819.24,019,537,665.084,047,782,860.82
资产总计6,311,959,999.776,277,761,845.446,067,610,368.996,086,827,335.16
流动负债合计348,911,941.1373,326,272.29261,015,167.72276,695,658.86
非流动负债合计83,334,749.8294,398,070.79113,864,322.29117,449,135.19
负债合计432,246,690.92467,724,343.08374,879,490.01394,144,794.05
归属于母公司股东权益合计5,870,750,718.225,800,616,100.165,682,915,408.565,682,511,453.93
股东权益合计5,879,713,308.855,810,037,502.365,692,730,878.985,692,682,541.11
负债和股东权益合计6,311,959,999.776,277,761,845.446,067,610,368.996,086,827,335.16
双鹭药业(002038)现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计273,602,084.461,181,283,435.22787,566,106.11595,021,228.1
经营活动现金流出小计166,855,009.22721,086,138.72563,284,455.89404,768,264.71
经营活动产生的现金流量净额106,747,075.24460,197,296.5224,281,650.22190,252,963.39
投资活动现金流入小计3,300,000636,440,359.08154,964,404.82141,075,198.82
投资活动现金流出小计28,093,699.08981,090,791.25230,924,812.33190,086,389.8
投资活动产生的现金流量净额-24,793,699.08-344,650,432.17-75,960,407.51-49,011,190.98
筹资活动现金流入小计----
筹资活动现金流出小计-102,735,000102,735,000102,735,000
筹资活动产生的现金流量净额--102,735,000-102,735,000-102,735,000
汇率变动对现金及现金等价物的影响-2.8332,957.831,870.641,877.66
现金及现金等价物净增加额81,953,373.3312,844,822.1645,588,113.3538,508,650.07
期末现金及现金等价物余额621,996,815.09540,043,441.76572,786,732.95565,707,269.67
双鹭药业002038相关数据
今日股市大盘指数